CQC report on the safer management of Controlled Drugs
The Care Quality Commission (CQC) produces an annual update on the management of controlled drugs and this latest report includes guidance on:
- the increase in opioid prescribing across the UK and the associated risk of dependence
- measures put in place following the Gosport Independent Panel report
- continuing concerns regarding lower schedule controlled drugs
- the introduction of legislation for the use of cannabis-based medicinal products.
The lower schedule controlled drugs include benzodiazepines, dihydrocodeine, codeine and similar medicines that do not require special secure storage or records kept in a controlled drugs register. Some of these drugs can be purchased as over-the-counter medicines in pharmacies, without a prescription. However, there is increasing evidence that these drugs are being misused and the CQC recommends that health care staff should consider regularly monitoring and auditing controlled drugs in Schedules 4 and 5. The Ashtons Drugs Liable for Misuse Record Book is designed for this purpose and could be a useful tool for monitoring medicines identified as high-risk.
The Ashtons Drugs Liable for Misuse Book can be ordered from our online ordering website:
For more information: